Get the Stockscreener App
5.66
1.39%
-0.08
Pepgen Inc stock is traded at $5.66, with a volume of 314.35K.
It is down -1.39% in the last 24 hours and up +10.33% over the past month.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
See More
Previous Close:
$5.74
Open:
$5.74
24h Volume:
314.35K
Relative Volume:
0.11
Market Cap:
$389.11M
Revenue:
-
Net Income/Loss:
$-87.23M
P/E Ratio:
-1.9057
EPS:
-2.97
Net Cash Flow:
$-82.77M
1W Performance:
+4.04%
1M Performance:
+10.33%
6M Performance:
+285.03%
1Y Performance:
+9.69%
1-Day Range:
$5.61
$5.93
1-Week Range:
$5.03
$5.98
52-Week Range:
$0.8801
$6.72
Pepgen Inc Stock (PEPG) Company Profile
Name
Pepgen Inc
Sector
Industry
Phone
703-456-8000
Address
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
5.66 | 394.61M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-25 | Initiated | Guggenheim | Buy |
| Dec-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-21-22 | Initiated | H.C. Wainwright | Buy |
Pepgen Inc Stock (PEPG) Latest News
Movement Recap: How buybacks impact PepGen Inc stock valueQuarterly Growth Report & Daily Profit Maximizing Trade Tips - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Stockholders to Connect - ACCESS Newswire
How Much Upside is Left in PepGen (PEPG)? Wall Street Analysts Think 75.44% - Zacks Investment Research
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer - BioSpace
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer - BioSpace
Quant Funds Rotate Into Lead Reclaim and Rubber Products Limited StockSwing Trading Ideas & Superior Wealth Growth - earlytimes.in
What analysts say about PepGen Inc stockStock Split Announcements & Identify Winning Stocks - earlytimes.in
Is Sterlite Technologies Limited Positioned to Benefit From Geographic ExpansionPrice Momentum Alerts & Big Gains Small Capital - earlytimes.in
Nettlinx Limited Inches Toward Key Resistance Will It BreakStock Market Trends & Small Investment Capital Tips - earlytimes.in
PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Hold" by Analysts - MarketBeat
PepGen (NASDAQ:PEPG) Targets Next-Gen Treatment Pathways In Biotech - Kalkine Media
PepGen appoints Joseph Vittiglio as chief business, legal officer - TipRanks
PepGen appoints Joseph Vittiglio as chief business and legal officer - Investing.com
PepGen appoints Joseph Vittiglio, Esq., as chief business and legal officer - marketscreener.com
PepGen Inc. Appoints New Chief Business Officer - TipRanks
PepGen appoints Joseph Vittiglio as chief business and legal officer By Investing.com - Investing.com Canada
PepGen Inc Appoints New Chief Business and Legal Officer - TradingView — Track All Markets
Pepgen Inc. Appoints Joseph Vittiglio as Chief Business and Legal Officer, Effective December 8, 2025 - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Encourages PepGen Inc. (PEPG) Investors to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages PepGen Inc. (PEPG) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
PepGen (PEPG) Stock Analysis Report | Financials & Insights - Benzinga
PEPG SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Class Action Lawsuit Filed Against PepGen Inc. (PEPG)Recover L - The National Law Review
Lost Money on PepGen Inc. (PEPG)? Join Class Action Before August 8, 2025Contact Levi & Korsinsky - The National Law Review
PepGen (PEPG) Price Target Increased by 17.65% to 10.20 - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PepGen Inc. (PEPG) And Encourages Shareholders to Reach Out - ACCESS Newswire
PEPG Investors Have the Opportunity to Lead the PepGen Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Aktiellt
PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - ADVFN
What date does PepGen's (PEPG) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
32,799,724 Common Stock of PepGen Inc. are subject to a Lock-Up Agreement Ending on 24-NOV-2025. - MarketScreener
Bronstein, Gewirtz & Grossman, LLC Encourages PepGen Inc. (PEPG) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Compugen (NASDAQ:CGEN) versus PepGen (NASDAQ:PEPG) Critical Review - Defense World
Can PepGen Inc. stock beat analyst upgradesMarket Activity Recap & Long-Term Growth Portfolio Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Why retail investors pile into PepGen Inc. stockDividend Hike & Safe Capital Growth Stock Tips - newser.com
Will PepGen Inc. price bounce be sustainable2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com
What risks investors should watch in PepGen Inc. stockMarket Performance Report & Capital Protection Trading Alerts - newser.com
PepGen Inc. (PEPG) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
PepGen Investor Drops Suit Over Muscular Dystrophy Drug Study - Bloomberg Law News
Can PepGen Inc. stock attract ESG capital inflows2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - newser.com
Will PepGen Inc. see short term momentumShort Setup & Safe Entry Momentum Stock Tips - newser.com
Smart tools for monitoring PepGen Inc.’s price actionPortfolio Update Summary & AI Powered Trade Plan Recommendations - newser.com
Is PepGen (NASDAQ:PEPG) In A Good Position To Deliver On Growth Plans? - Sahm
Advanced analytics toolkit walkthrough for PepGen Inc.2025 Volatility Report & Stepwise Swing Trade Plans - newser.com
Will PepGen Inc. continue its uptrend2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Tools to monitor PepGen Inc. recovery probabilityShare Buyback & Low Drawdown Momentum Ideas - newser.com
Is PepGen Inc. stock trading near support levelsJuly 2025 Big Picture & Weekly High Return Stock Forecasts - newser.com
Pepgen Inc Stock (PEPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):